<?xml version="1.0" encoding="UTF-8"?>
<p>The focus of the current model was key critical care drugs required in the COVID-19 pandemic, however, the model is transferrable to other therapeutic classes and settings and has the potential to assist in informing medicine planning and preparedness in future epidemics/pandemics. For example, the model is currently being used in palliative care and drugs, doses, % uptake, % usage split and typical duration of treatment have been reviewed and agreed by the Regional Palliative Medicine Group and NI Specialist Palliative Care Pharmacist Group.</p>
